In some cancers, however, the TP53 mutation frequency is lower but other mechanisms, such as altered expression or mutation of p53 regulators (e.g. MDM2, MDM4, ARF) are thought to eliminate p53 function [31]. The gene discussed is MDM2; the disease is cancer.